Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |